# Application and Effect Evaluation of Medium Chain Fatty Acid Rich Milk Powder in Infants With Cholestatic Liver Disease

> **NCT05922332** · NA · WITHDRAWN · sponsor: **Children's Hospital of Fudan University**

## Conditions studied

- Cholestatic Liver Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Rich medium chain fatty acid milk powder group
- **DIETARY_SUPPLEMENT:** Regular milk powder group

## Key facts

- **NCT ID:** NCT05922332
- **Lead sponsor:** Children's Hospital of Fudan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-04-01
- **Primary completion:** 2025-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study could not be conducted as a randomized controlled study due to a change in the protocol, and the study needs to be stopped.
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05922332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05922332, "Application and Effect Evaluation of Medium Chain Fatty Acid Rich Milk Powder in Infants With Cholestatic Liver Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05922332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*